首页>
外国专利>
TREATMENT OF MULTIPLE SCLEROSIS USING COP-1 AND TH-2 ENHANCING CYTOKINES
TREATMENT OF MULTIPLE SCLEROSIS USING COP-1 AND TH-2 ENHANCING CYTOKINES
展开▼
机译:COP-1和TH-2增强细胞因子治疗多发性硬化症
展开▼
页面导航
摘要
著录项
相似文献
摘要
The invention relates to a treatment for multiple sclerosis. COP-1 (copolymer-1), a synthetic polymer consisting of a mixture of random synthetic polypeptides composed of L-alanine, L-glutamic acid, L-lysine and L-tyrosine in a molar ratio of about 6:2:5:1, is administered mucosally to patients afflicted with the disease in combination with Th2 enhancing cytokines such as IL-4 or IL-10. The combination treatment of IL-4 or IL-10 (preferably orally administered) with mucosally administered COP-1 shows a substantially greater suppressive effect than does treatment with cytokine or COP-1 alone.
展开▼